News Letter from IPC – Materiovigilance Programme of India
Download the News Letter on Materiovigilance Program of India from IPC from here :
About MvPI – Materiovigilance Programme of India :
Materiovigilance Programme of India was launched by DCG (I) on 6th July 2015 at Indian Pharmacopoeia Commission (IPC) Ghaziabad. Indian Pharmacopoeia Commission functions as a National Coordination Centre (NCC) for MvPI.
After several horrific cases of malfunctioning medical devices, like babies being burnt to death due to short circuits in incubators or hip implants causing blood poisoning, the Ministry of Health & Family Welfare (MoHFW), Govt. of India (GoI) has approved Materiovigilance Programme of India (MvPI) in an effort to ensure safety of medical devices. In addition to
protection of health and safety of patients, Materiovigilance program reduces the likelihood of reoccurrence of the harmful incidents elsewhere thereby improving quality of health products.
Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST),
Thiruvananthapuram, shall act as National Collaboration Centre, National Health System Resource Centre (NHSRC), New Delhi shall act as Technical Support & Resource Centre and Central Drugs Standard Control Organisation (CDSCO), New Delhi shall act as Regulator.
For more information and updates, visit –
http://www.ipc.gov.in/mandates/pvpi/materiovigilance-programme-of-india-mvpi.html